Guided hydration to protect kidneys in elderly heart patients
Part of Heart & circulation, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a new way to manage fluids during heart procedures to prevent kidney injury. It uses a special vest that measures lung fluid to guide how much hydration you get.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 60 or older
- Have unstable angina and scheduled for a heart procedure with stents
- Have chronic kidney disease with moderately reduced kidney function
- No severe heart failure or shock
- No cancer or advanced kidney failure
- No allergy to contrast dye used in imaging
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if using a wearable monitor (ReDS) to guide fluid removal helps people hospitalized for heart failure. The goal is to find the right amount of fluid to remove so patients feel better and stay out of the hospital.
This trial tests whether drinking extra water during treatment for a heart attack can help prevent kidney damage caused by the heart procedure. If you are eligible, this could be a simple way to protect your kidneys.
This trial studies whether a device called Dye-Vert Plus can lower the risk of kidney injury from contrast dye during heart catheter procedures (CAG and/or PCI). It focuses on people at higher kidney risk, especially those with diabetes or high blood pressure.
This study looks at ways to improve kidney outcomes after a coronary angiogram and/or stent procedure. If you’re having one of these heart procedures and your kidneys aren’t already severely affected, the study may help reduce the risk of kidney worsening around the time of the procedure.
This trial tests a new way to manage fluids during heart surgery with the goal of protecting your kidneys. It uses a special device to guide fluid levels and checks early signs of kidney injury.
This trial tests a device to help the kidneys remove excess fluid in people hospitalized for worsening heart failure who are not responding well to standard diuretic (water pill) therapy. It aims to improve heart and kidney function.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.